CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- S-3/A Offering Registration Statement
- 10-K/A Report 10-K/A
- 10-Q Report Quarterly Report
- S-3/A Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- DEFS14A Other DEFS14A
- PRES14A Other PRES14A
- 10-Q Report Quarterly Report
- RW Other RW
- S-3/A Offering Registration Statement
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
Page 102 of 104 · 2,077 filings